FDA Drug Application (021887) for ALLI by GLAXOSMITHKLINE CONS

Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS

Application Number021887
Product Number001
FormCAPSULE;ORAL
Dosage60MG
Product Market Status Over The Counter
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameALLI
Active IngredientORLISTAT

Active IngredientCount
List of drugs with Active Ingredient ORLISTAT2


Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS